US Stock MarketDetailed Quotes

SINO BIOPHARMACEUT (SBHMY)

Watchlist
  • 14.200
  • 0.0000.00%
15min DelayClose Apr 23 13:48 ET
12.69BMarket Cap37.37P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

SINO BIOPHARMACEUT (SBHMY) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(FY)Dec 31, 2024
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(Q2)Jun 30, 2021
(Q1)Mar 31, 2021
(FY)Dec 31, 2020
(Q4)Dec 31, 2020
(Q3)Sep 30, 2020
Total revenue
10.28%31.83B
10.18%28.87B
0.67%26.2B
-3.11%26.03B
13.59%26.86B
10.66%7.11B
16.41%7.24B
-2.42%23.65B
12.38%5.52B
-19.36%5.48B
Operating revenue
10.28%31.83B
10.18%28.87B
0.67%26.2B
-3.11%26.03B
13.59%26.86B
10.66%7.11B
16.41%7.24B
-2.42%23.65B
12.38%5.52B
-19.36%5.48B
Cost of revenue
6.96%5.71B
6.94%5.34B
11.19%4.99B
-15.84%4.49B
2.89%5.33B
-12.31%1.34B
11.75%1.42B
5.20%5.18B
-4.10%1.11B
-2.77%1.28B
Gross profit
11.04%26.13B
10.94%23.53B
-1.53%21.21B
0.04%21.54B
16.60%21.53B
17.81%5.77B
17.60%5.83B
-4.37%18.46B
17.44%4.41B
-23.36%4.2B
Operating expense
11.81%19.23B
13.70%17.2B
-5.83%15.12B
-6.50%16.06B
21.29%17.18B
15.27%3.98B
16.97%4.57B
0.36%14.16B
33.51%3.66B
-16.40%3.14B
Selling and administrative expenses
8.04%13.14B
9.88%12.16B
-5.48%11.07B
-7.83%11.71B
9.25%12.7B
20.32%3.29B
19.44%3.5B
-1.43%11.63B
19.58%2.97B
-10.42%2.99B
-Selling and marketing expense
9.08%10.99B
9.62%10.08B
-6.28%9.19B
-6.74%9.81B
17.23%10.52B
23.12%2.61B
22.58%3.05B
-3.72%8.97B
22.44%2.11B
-15.45%2.25B
-General and administrative expense
2.98%2.14B
11.12%2.08B
-1.38%1.87B
-13.08%1.9B
-17.72%2.19B
10.65%678.3M
1.69%448.06M
7.21%2.66B
13.11%862.62M
9.38%739.67M
Research and development costs
15.27%5.87B
15.59%5.09B
5.73%4.4B
--4.16B
----
----
4.18%1.01B
----
----
----
Other operating expenses
290.37%338.17M
-71.19%86.63M
0.62%300.69M
-93.55%298.82M
69.25%4.63B
-3.73%703.73M
10.02%1.08B
6.77%2.74B
83.69%863.76M
-63.37%158.28M
Operating profit
8.93%6.9B
4.08%6.33B
11.07%6.09B
25.87%5.48B
1.15%4.35B
23.87%1.79B
19.94%1.26B
-17.20%4.3B
-25.79%755.64M
-38.61%1.05B
Net non-operating interest income expense
73.78%355.28M
274.89%204.45M
49.95%-116.9M
-59.38%-233.59M
-13.29%-146.56M
-259.72%-30.3M
-34.16%-17.62M
-566.03%-129.37M
-1,472.08%-71.16M
-361.84%-36.66M
Non-operating interest income
26.83%633.59M
32.04%499.56M
93.12%378.34M
20.89%195.91M
-16.47%162.06M
-40.02%45.27M
-30.08%54.04M
-24.72%194M
-113.01%-13.25M
-10.78%54.48M
Non-operating interest expense
-5.69%278.31M
-40.41%295.12M
15.31%495.24M
39.17%429.49M
-4.56%308.62M
-9.93%75.56M
-20.76%71.66M
40.63%323.37M
-40.09%57.91M
93.64%91.14M
Other net income (expense)
Special income (charges)
96.43%-40.32M
-2,494.10%-1.13B
-152.08%-43.51M
612.71%83.54M
-455.76%-16.29M
488.15%794K
387.21%1.07M
407.20%4.58M
127.34%4.12M
-99.32%108K
-Less：Restructuring and merger&acquisition
-129.99%-20.42M
511.58%68.09M
81.55%-16.54M
-846.23%-89.67M
--12.02M
----
----
----
----
----
-Less:Impairment of capital assets
-76.00%71.92M
8,575.16%299.6M
---3.54M
----
----
----
----
----
----
----
-Less:Other special charges
-102.69%-11.17M
553.21%415.36M
937.99%63.59M
43.20%6.13M
193.41%4.28M
-488.15%-794K
-387.21%-1.07M
-407.20%-4.58M
-127.34%-4.12M
---108K
-Write off
--0
--326.98M
--0
----
----
----
----
----
----
----
Other non- operating income (expenses)
-105.89%-331.61M
-26.18%-161.06M
-222.86%-127.64M
-68.16%103.89M
385.63%326.33M
-29.32%22.74M
156.28%49.87M
37.33%67.2M
-13.85%-8.73M
67.36%24.3M
Income before tax
31.57%6.94B
-2.45%5.28B
3.74%5.41B
-71.92%5.21B
270.49%18.57B
517.66%8.14B
119.74%2.84B
-11.91%5.01B
5.57%1.27B
-38.98%1.13B
Income tax
230.45%1.63B
-38.17%492.92M
14.43%797.27M
-64.41%696.72M
191.19%1.96B
169.81%889.97M
106.47%446.94M
-25.52%672.38M
-249.41%-105.32M
-39.53%231.37M
Net income
-16.50%5.31B
24.86%6.36B
1.89%5.1B
-69.89%5B
282.77%16.61B
633.84%7.25B
122.41%2.39B
-9.34%4.34B
21.40%1.38B
-38.84%898.44M
Net income continuous Operations
11.08%5.31B
3.73%4.78B
2.09%4.61B
-72.81%4.52B
282.77%16.61B
633.84%7.25B
122.41%2.39B
-9.34%4.34B
21.40%1.38B
-38.84%898.44M
Net income discontinuous operations
--0
225.96%1.58B
0.06%484.76M
--484.47M
----
----
----
----
----
----
Minority interest income
3.71%2.97B
3.59%2.86B
12.46%2.77B
22.56%2.46B
27.83%2.01B
9.25%680.35M
139.53%480.92M
-22.54%1.57B
-27.28%457.51M
-56.13%288.55M
Net income attributable to the parent company
-33.04%2.34B
50.08%3.5B
-8.32%2.33B
-82.59%2.54B
427.17%14.61B
1,700.00%6.57B
118.49%1.91B
0.35%2.77B
81.93%920.59M
-24.81%609.89M
Preferred stock dividends
Other preferred stock dividends
0
100.37%788K
-190.89%-211.2M
-51.84%232.37M
482.51M
96.90%-11.24M
-29.52%123.77M
0
0
186.4M
Net income attributable to common stockholders
-33.03%2.34B
37.59%3.5B
10.04%2.54B
-83.64%2.31B
409.76%14.13B
805.03%6.58B
155.61%1.79B
0.35%2.77B
81.93%920.59M
-47.79%423.49M
Basic earnings per share
-31.94%2.604
51.95%3.826
-7.43%2.518
-82.53%2.72
428.02%15.566
1,702.06%6.992
118.67%2.038
0.41%2.948
80.59%0.986
-25.41%0.642
Diluted earnings per share
-32.15%2.596
51.95%3.826
3.62%2.518
-83.42%2.43
397.01%14.652
1,657.73%6.82
151.49%1.856
0.41%2.948
80.59%0.986
-25.41%0.642
Dividend per share
49.83%1.648
-26.04%1.0999
-14.58%1.4873
74.41%1.7411
-15.21%0.9983
36.46%0.6659
0
23.52%1.1773
40.66%0.337
45.40%0.3523
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2025(FY)Dec 31, 2024(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(Q2)Jun 30, 2021(Q1)Mar 31, 2021(FY)Dec 31, 2020(Q4)Dec 31, 2020(Q3)Sep 30, 2020
Total revenue 10.28%31.83B10.18%28.87B0.67%26.2B-3.11%26.03B13.59%26.86B10.66%7.11B16.41%7.24B-2.42%23.65B12.38%5.52B-19.36%5.48B
Operating revenue 10.28%31.83B10.18%28.87B0.67%26.2B-3.11%26.03B13.59%26.86B10.66%7.11B16.41%7.24B-2.42%23.65B12.38%5.52B-19.36%5.48B
Cost of revenue 6.96%5.71B6.94%5.34B11.19%4.99B-15.84%4.49B2.89%5.33B-12.31%1.34B11.75%1.42B5.20%5.18B-4.10%1.11B-2.77%1.28B
Gross profit 11.04%26.13B10.94%23.53B-1.53%21.21B0.04%21.54B16.60%21.53B17.81%5.77B17.60%5.83B-4.37%18.46B17.44%4.41B-23.36%4.2B
Operating expense 11.81%19.23B13.70%17.2B-5.83%15.12B-6.50%16.06B21.29%17.18B15.27%3.98B16.97%4.57B0.36%14.16B33.51%3.66B-16.40%3.14B
Selling and administrative expenses 8.04%13.14B9.88%12.16B-5.48%11.07B-7.83%11.71B9.25%12.7B20.32%3.29B19.44%3.5B-1.43%11.63B19.58%2.97B-10.42%2.99B
-Selling and marketing expense 9.08%10.99B9.62%10.08B-6.28%9.19B-6.74%9.81B17.23%10.52B23.12%2.61B22.58%3.05B-3.72%8.97B22.44%2.11B-15.45%2.25B
-General and administrative expense 2.98%2.14B11.12%2.08B-1.38%1.87B-13.08%1.9B-17.72%2.19B10.65%678.3M1.69%448.06M7.21%2.66B13.11%862.62M9.38%739.67M
Research and development costs 15.27%5.87B15.59%5.09B5.73%4.4B--4.16B--------4.18%1.01B------------
Other operating expenses 290.37%338.17M-71.19%86.63M0.62%300.69M-93.55%298.82M69.25%4.63B-3.73%703.73M10.02%1.08B6.77%2.74B83.69%863.76M-63.37%158.28M
Operating profit 8.93%6.9B4.08%6.33B11.07%6.09B25.87%5.48B1.15%4.35B23.87%1.79B19.94%1.26B-17.20%4.3B-25.79%755.64M-38.61%1.05B
Net non-operating interest income expense 73.78%355.28M274.89%204.45M49.95%-116.9M-59.38%-233.59M-13.29%-146.56M-259.72%-30.3M-34.16%-17.62M-566.03%-129.37M-1,472.08%-71.16M-361.84%-36.66M
Non-operating interest income 26.83%633.59M32.04%499.56M93.12%378.34M20.89%195.91M-16.47%162.06M-40.02%45.27M-30.08%54.04M-24.72%194M-113.01%-13.25M-10.78%54.48M
Non-operating interest expense -5.69%278.31M-40.41%295.12M15.31%495.24M39.17%429.49M-4.56%308.62M-9.93%75.56M-20.76%71.66M40.63%323.37M-40.09%57.91M93.64%91.14M
Other net income (expense)
Special income (charges) 96.43%-40.32M-2,494.10%-1.13B-152.08%-43.51M612.71%83.54M-455.76%-16.29M488.15%794K387.21%1.07M407.20%4.58M127.34%4.12M-99.32%108K
-Less：Restructuring and merger&acquisition -129.99%-20.42M511.58%68.09M81.55%-16.54M-846.23%-89.67M--12.02M--------------------
-Less:Impairment of capital assets -76.00%71.92M8,575.16%299.6M---3.54M----------------------------
-Less:Other special charges -102.69%-11.17M553.21%415.36M937.99%63.59M43.20%6.13M193.41%4.28M-488.15%-794K-387.21%-1.07M-407.20%-4.58M-127.34%-4.12M---108K
-Write off --0--326.98M--0----------------------------
Other non- operating income (expenses) -105.89%-331.61M-26.18%-161.06M-222.86%-127.64M-68.16%103.89M385.63%326.33M-29.32%22.74M156.28%49.87M37.33%67.2M-13.85%-8.73M67.36%24.3M
Income before tax 31.57%6.94B-2.45%5.28B3.74%5.41B-71.92%5.21B270.49%18.57B517.66%8.14B119.74%2.84B-11.91%5.01B5.57%1.27B-38.98%1.13B
Income tax 230.45%1.63B-38.17%492.92M14.43%797.27M-64.41%696.72M191.19%1.96B169.81%889.97M106.47%446.94M-25.52%672.38M-249.41%-105.32M-39.53%231.37M
Net income -16.50%5.31B24.86%6.36B1.89%5.1B-69.89%5B282.77%16.61B633.84%7.25B122.41%2.39B-9.34%4.34B21.40%1.38B-38.84%898.44M
Net income continuous Operations 11.08%5.31B3.73%4.78B2.09%4.61B-72.81%4.52B282.77%16.61B633.84%7.25B122.41%2.39B-9.34%4.34B21.40%1.38B-38.84%898.44M
Net income discontinuous operations --0225.96%1.58B0.06%484.76M--484.47M------------------------
Minority interest income 3.71%2.97B3.59%2.86B12.46%2.77B22.56%2.46B27.83%2.01B9.25%680.35M139.53%480.92M-22.54%1.57B-27.28%457.51M-56.13%288.55M
Net income attributable to the parent company -33.04%2.34B50.08%3.5B-8.32%2.33B-82.59%2.54B427.17%14.61B1,700.00%6.57B118.49%1.91B0.35%2.77B81.93%920.59M-24.81%609.89M
Preferred stock dividends
Other preferred stock dividends 0100.37%788K-190.89%-211.2M-51.84%232.37M482.51M96.90%-11.24M-29.52%123.77M00186.4M
Net income attributable to common stockholders -33.03%2.34B37.59%3.5B10.04%2.54B-83.64%2.31B409.76%14.13B805.03%6.58B155.61%1.79B0.35%2.77B81.93%920.59M-47.79%423.49M
Basic earnings per share -31.94%2.60451.95%3.826-7.43%2.518-82.53%2.72428.02%15.5661,702.06%6.992118.67%2.0380.41%2.94880.59%0.986-25.41%0.642
Diluted earnings per share -32.15%2.59651.95%3.8263.62%2.518-83.42%2.43397.01%14.6521,657.73%6.82151.49%1.8560.41%2.94880.59%0.986-25.41%0.642
Dividend per share 49.83%1.648-26.04%1.0999-14.58%1.487374.41%1.7411-15.21%0.998336.46%0.6659023.52%1.177340.66%0.33745.40%0.3523
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -